Prevalence of the cefazolin inoculum effect (CzIE) in nasal colonizing methicillin-susceptible Staphylococcus aureus in patients from intensive care units in Colombia and use of a modified rapid nitrocefin test for detection
Authors:
- 6 November 2024
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 68 (11) , e0089824
Abstract
The cefazolin inoculum effect (CzIE) has been associated with poor clinical outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) infections. We aimed to investigate the point prevalence of the CzIE among nasal colonizing MSSA isolates from ICU patients in a multicenter study in Colombia (2019–2023). Patients underwent nasal swabs to assess for S. aureus colonization on admission to the ICU, and some individuals had follow-up swabs. We performed cefazolin MIC by broth microdilution using standard and high inoculum and developed a modified nitrocefin-based rapid test to detect the CzIE. Whole-genome sequencing was carried out to characterize BlaZ types and allotypes, phylogenomics, and Agr-typing. A total of 352 patients were included; 46/352 (13%) patients were colonized with S. aureus and 22% (10/46) and 78% (36/46) with MRSA and MSSA, respectively. Among 36 patients who contributed with 43 MSSA colonizing isolates, 21/36 (58%) had MSSA exhibiting the CzIE. BlaZ type A and BlaZ-2 were the predominant type and allotype in 56% and 52%, respectively. MSSA belonging to CC30 were highly associated with the CzIE, and single-nucleotide polymorphism (SNP) analyses supported possible transmission of MSSA exhibiting the CzIE among some patients of the same unit. The modified nitrocefin rapid test had 100%, 94.4%, and 97.7% sensitivity, specificity, and accuracy, respectively. We found a high point prevalence of the CzIE in MSSA colonizing the nares of critically ill patients in Colombia. A modified rapid test was highly accurate in detecting the CzIE in this patient population.Keywords
Funding Information
- Ministerio de Ciencia, Tecnología e Innovación (130880764152-CT 776-2018)
- Universidad El Bosque (PCI 2023-002)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (K24AI121296)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R01AI134637)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R01AI148342)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R01AI173138)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (T32AI179595)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (P01AI152999)
This publication has 45 references indexed in Scilit:
- Risk of multi-drug-resistant organism acquisition from prior bed occupants in the intensive care unit: a meta-analysisJournal of Hospital Infection, 2023
- Comparison of Nafcillin and Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus BacteremiaThe American Journal of the Medical Sciences, 2020
- A comparison of safety and outcomes with cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bloodstream infectionsJournal of Microbiology, Immunology and Infection, 2020
- Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in KoreaClinical Microbiology and Infection, 2018
- The cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus blood isolates: their association with dysfunctional accessory gene regulator (agr)Diagnostic Microbiology and Infectious Disease, 2015
- Prevalence of blaZ gene types and the cefazolin inoculum effect among methicillin-susceptible Staphylococcus aureus blood isolates and their association with multilocus sequence types and clinical outcomeEuropean Journal of Clinical Microbiology & Infectious Diseases, 2014
- Phylogeny-aware alignment with PRANK2013
- Staphylococcus aureus colonisation: some questions answeredThe Lancet Infectious Diseases, 2013
- Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriersThe Lancet, 2004
- Obvious Lack of Association Between Dynamics of Epidemic Methicillin-Resistant Staphylococcus aureus in Central Europe and agr Specificity GroupsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004